Syneos Health
Drug development built on outcomes
Morrisville, North Carolina, US
Syneos Health is a fully integrated biopharmaceutical solutions organization providing contract research and commercial services. The company was taken private in September 2023 for a $4.46 billion equity value and boasts a global workforce of over 26,000 employees. They have played a significant role in the development and commercialization of a high percentage of FDA-approved novel drugs and EMA-authorized products.
How We Help
Problem Statement
Bringing new health treatments to market efficiently by providing integrated services for late-stage clinical trials and commercialization.
Core Technology
Clinical trial management and commercialization services infrastructure
Key Differentiators
Integrated clinical research (CRO) and commercialization services
Clinical Focus
Clinical Trials; Drug Development
Company Info
- Business Model
- B2B
- Website
- www.syneoshealth.com
Categories
Disease Areas
Technologies
Clinical & IP
Clinical Validation
93% involvement in novel FDA-approved drugs; 96% of oncology drug approvals; 89% of CNS medications. Leading decentralized trial capabilities through partnerships including Medable for technology integration.
MedStartr Index Score
?What do you think of Syneos Health?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.